Active — Not RecruitingNot Applicable

Registry on Percutaneous Electrochemotherapy

France, Germany250 participantsStarted 2023-01-25

Plain-language summary

The Registry on Percutaneous ElectroChemoTherapy (RESPECT) is a post-market, prospective, non-randomized, observational study aiming at evaluating the effectiveness of percutaneous electrochemotherapy (ECT) for the treatment of liver cancer.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 18 years or older * Primary or secondary liver cancer * Referral to local ablative treatment by multidisciplinary tumour board and decision to treat with pECT by interventional radiologist in charge * Planned treatment with pECT using the CLINIPORATOR * Signed informed consent form Exclusion Criteria: Pregnancy

What they're measuring

Local Tumour Control

Timeframe: 12 months

Trial details

NCT IDNCT05267080

SponsorCardiovascular and Interventional Radiological Society of Europe

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-01-23

View on ClinicalTrials.gov More Primary Liver Cancer trials